Login

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
ASSETS
Current assets
Cash
Accounts and other receivables, net
Derivative instruments (note 5)
Related party receivables (note 4)
Inventory
Prepaid expenses and other current assets
Total current assets
Equity investments
Property, plant and equipment
Oil and natural gas properties
Other property, plant and equipment
Property, Plant and Equipment, Gross
Accumulated depletion, depreciation, and impairment (note 5)
Net property, plant and equipment
Other long-term assets
Intangibles, net
Goodwill
Derivative instruments (note 5)
Other long-term assets (note 6)
Total assets
LIABILITIES AND EQUITY
Current liabilities
Accounts payable
Long-term Debt, Current Maturities
Derivative instruments (note 5)
Distributions payable
Debtor-in-Possession Financing, Borrowings Outstanding
Current portion of asset retirement obligation
Revenue and royalties payable
Wages and salaries payable
Accrued interest payable
Production and property taxes payable
Other current liabilities
Total current liabilities
Credit facility
Liabilities subject to compromise (note 2)
Credit agreement (note 9)
Other long-term debt
Senior notes, net (note 9)
Other long-term debt (note 9)
Long-term debt (note 7)
Deferred income taxes
Asset retirement obligation (note 9)
Derivative instruments (note 5)
Other long-term liabilities
Total liabilities
Equity
Series A preferred units, 8.0 million units issued and outstanding at each of September 30, 2017 and December 31, 2016 (note 11)
Series B preferred units, 49.6 million units issued and outstanding at each of September 30, 2017 and December 31, 2016 (note 11)
Common unitholders' (deficit) equity, 213.8 million units issued and outstanding at each of September 30, 2017 and December 31, 2016 (note 11)
Accumulated other comprehensive income (note 12)
Total partners' (deficit) equity
Noncontrolling interest
Total (deficit) equity
Total liabilities and equity
Common units issued and outstanding
Common Units
Total common units issued and outstanding
Common units issued and outstanding

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support